We are delighted to announce that our seminal paper A novel process driving Alzheimer’s validated in a mouse model: therapeutic potential’ has been accepted by the peer-reviewed journal Alzheimer’s & Dementia: Translational Research & Clinical...
Great success for Neuro-bio’s CEO, Susan Greenfield at the Rosalind Franklin Institute on Thursday 27.01. She talked about the assets that the company is currently working on and had the chance to talk and meet the audience. The Neuro-bio’s team was there...
Neuro-Bio has been mentioned as Global Alzheimer’s Disease Diagnostic Market Key Player by Maximize market research pvt. ltd. To read the full article, click the link.
On Thursday 27th of January, Neuro-Bio’s CEO, Susan Greenfield, will talk at the Rosalind Franklin Institute Seminar. Neuro-Bio staff will participate and hear her talk, whose title is : DISRUPTIVE DISCOVERIES INSPIRED BY A BASIC BIOLOGICAL PROCESS. To learn...
Considering the increase spreading of the virus Covid-19, Neuro-Bio Ltd is performing routine lateral flow tests at least once a week to its employees. This will make sure that everyone at Neuro-Bio is safe and monitored and will allow visitors to come on site without...
The Spanish economy newspaper called “ElReferente” interviewed Neuro-Bio’s Operations Director, Sara Garcia-Rates. She talked about the company’s history, the novel approach to AD, the project with Rising Up Spain and the future plans. To read...
